Cervical Cancer Treatment Market Outlook
The cervical cancer treatment market is estimated to increase from US$9.3 Bn in 2024 to US$13.9 Bn by 2031. The market is projected to record a CAGR of 5.9% during the forecast period from 2024 to 2031. Increased adoption of immunotherapies like Keytruda, enhancing treatment outcomes leading the market forward during the forecast period. North America to dominate the market with significant market share in 2024.